Korea’s medicine business at a crossroads

With retail prices of 8,776 drugs out of the total 14,410 listed on the national health insurance that are expected to fall about 17 percent on average beginning next year following a set of government-led reforms, many experts say that the country's medicine business is standing at a crossroads.

Is it going take a leap with new, innovative drugs or continue chasing global leaders with copie...